サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1520407

血漿分画製剤市場レポート：タイプ、用途、エンドユーザー、地域別、2024年～2032年2

Blood Plasma Derivatives Market Report by Type, Application, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 145 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
血漿分画製剤市場レポート：タイプ、用途、エンドユーザー、地域別、2024年～2032年2
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血漿分画製剤の市場規模は2023年に458億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに741億米ドルに達し、2024年から2032年の間に5.4%の成長率（CAGR）を示すと予測しています。

血漿分画製剤は、血漿から分画された特定のタンパク質を濃縮したものです。第VIII因子、免疫グロブリン、アルブミン、高免疫グロブリン、第IX因子、新鮮凍結などは、一般的な血漿分画製剤の一部です。これらはタンパク質、ミネラル、塩類、ホルモン、ビタミン、プロテアーゼ阻害剤を豊富に含んでおり、B型肝炎、血友病A、出血性疾患、免疫不全、C型肝炎、低ガンマグロブリン血症、血友病B、ヒト免疫不全ウイルス（HIV）の原因となるウイルスを殺すために広く使用されています。これとは別に、血漿分画製剤は、栄養強化、体温調節、血液凝固、浸透圧維持、呼吸・排泄促進、酸塩基平衡調節を助ける。血漿分画製剤は、病院、診療所、診断センター、輸血センターなどで一般的に保存されています。

血漿分画製剤市場動向：

感染症に罹患しやすい高齢人口の増加が、市場に明るい展望をもたらしています。血漿には免疫の発達に重要な役割を果たす免疫グロブリンが含まれ、血管内の浸透圧を維持することで免疫不全症や血友病の発症を防ぎます。さらに、回復期血漿治療によるコロナウイルス感染症（COVID-19）患者の治療に広く製品が採用されていることも、市場の成長を後押ししています。さらに、臨床目的のために血漿中のタンパク質濃縮物や様々な成分を分離するのに役立つ分画プロセスにおける様々な技術革新が、市場成長にかなりの弾みをつけています。これに伴い、高度な保存方法の開拓や、標的治療薬開発のための封入手順の大幅な改善が、市場の成長をさらに押し上げています。ヘルスケア産業の著しい成長、献血および血漿提供に関する意識の高まり、献血キャンプを促進するための様々な政府イニシアチブの実施など、その他の要因も市場のさらなる成長を後押しすると予想されます。

本レポートで扱う主な質問

  • 2023年の世界の血漿分画製剤市場の市場規模は？
  • 2024-2032年の世界の血漿分画製剤市場の予想成長率は？
  • 世界の血漿分画製剤市場を牽引する主要因は？
  • 世界の血漿分画製剤市場に対するCOVID-19の影響は？
  • 世界の血漿分画製剤市場のタイプ別内訳は？世界の血漿分画製剤市場のエンドユーザー別内訳は？
  • 世界の血漿分画製剤市場の主要地域は？
  • 世界の血漿分画製剤市場の主要プレーヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の血漿分画製剤市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • アルブミン
    • 市場動向
    • 市場予測
  • 第VIII因子
    • 市場動向
    • 市場予測
  • 第IX因子
    • 市場動向
    • 市場予測
  • 免疫グロブリン
    • 市場動向
    • 市場予測
  • 高度免疫グロブリン
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳：用途別

  • 血友病
    • 市場動向
    • 市場予測
  • 低ガンマグロブリン血症
    • 市場動向
    • 市場予測
  • 免疫不全疾患
    • 市場動向
    • 市場予測
  • フォン・ヴィレブランド病
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Baxter International Inc.
    • Bayer AG
    • CSL Limited
    • Fusion Health Care Pvt. Ltd.
    • Grifols S.A.
    • Kedrion S.p.A.
    • LFB S.A.
    • Octapharma AG
    • Sanofi S.A.
    • Takeda Pharmaceutical Company Limited
図表

List of Figures

  • Figure 1: Global: Blood Plasma Derivatives Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Plasma Derivatives Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Blood Plasma Derivatives Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Blood Plasma Derivatives Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Blood Plasma Derivatives Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Blood Plasma Derivatives Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Blood Plasma Derivatives Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Blood Plasma Derivatives (Albumin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Blood Plasma Derivatives (Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Blood Plasma Derivatives (Factor VIII) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Blood Plasma Derivatives (Factor VIII) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Blood Plasma Derivatives (Factor IX) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Blood Plasma Derivatives (Factor IX) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Blood Plasma Derivatives (Immunoglobulin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Blood Plasma Derivatives (Immunoglobulin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Blood Plasma Derivatives (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Blood Plasma Derivatives (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Blood Plasma Derivatives (Hemophilia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Blood Plasma Derivatives (Hemophilia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Blood Plasma Derivatives (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Blood Plasma Derivatives (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Blood Plasma Derivatives (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Blood Plasma Derivatives (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Blood Plasma Derivatives (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Blood Plasma Derivatives (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Blood Plasma Derivatives (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Blood Plasma Derivatives (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: North America: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: North America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: United States: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: United States: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Canada: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Canada: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Asia-Pacific: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Asia-Pacific: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: China: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: China: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Japan: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Japan: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: India: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: India: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: South Korea: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: South Korea: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Australia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Australia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Indonesia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Indonesia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Europe: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Europe: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Germany: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Germany: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: France: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: France: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: United Kingdom: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: United Kingdom: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Italy: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Italy: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Spain: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Spain: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Russia: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Russia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Latin America: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Latin America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Brazil: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Brazil: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Mexico: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Mexico: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Others: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Middle East and Africa: Blood Plasma Derivatives Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Middle East and Africa: Blood Plasma Derivatives Market: Breakup by Country (in %), 2023
  • Figure 84: Middle East and Africa: Blood Plasma Derivatives Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Global: Blood Plasma Derivatives Industry: SWOT Analysis
  • Figure 86: Global: Blood Plasma Derivatives Industry: Value Chain Analysis
  • Figure 87: Global: Blood Plasma Derivatives Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Plasma Derivatives Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Blood Plasma Derivatives Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Blood Plasma Derivatives Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Blood Plasma Derivatives Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Blood Plasma Derivatives Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Blood Plasma Derivatives Market: Competitive Structure
  • Table 7: Global: Blood Plasma Derivatives Market: Key Players
目次
Product Code: SR112024A5371

The global blood plasma derivatives market size reached US$ 45.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 74.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032.

Blood plasma derivatives are concentrates of specific proteins prepared from plasma that are obtained through fractionation process. Factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX and fresh frozen are some of the common blood plasma derivatives. They are rich in proteins, minerals, salts, hormones, vitamins and protease inhibitors, due to which they are widely used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B and human immunodeficiency virus (HIV). Apart from this, blood plasma derivatives assist in enhancing nutrition, controlling body temperature and coagulation of blood, maintaining osmotic pressure, enhancing respiration and excretion, and regulating acid-base balance. Blood plasma derivatives are commonly stored at hospitals, clinics, diagnostic centers and blood transfusion centers.

Blood Plasma Derivatives Market Trends:

The increasing geriatric population that are more susceptible to developing infectious diseases are creating a positive outlook for the market. Blood plasma contains immunoglobulins that play an important role in the development of immunity and maintain the osmotic pressure in blood vessels, which further prevents the onset immunodeficiency disorders and hemophilia. Moreover, the widespread product adoption to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is favoring the market growth. Additionally, various technological innovations in the fractionation process that aids in separating protein concentrates and various components of blood plasma for clinical purposes are providing a considerable boost to the market growth. In line with this, the development of advanced preservation methods, along with the significant improvements in encased procedures for developing targeted therapeutic products are further augmenting the market growth. Other factors, including significant growth in the healthcare industry, increasing awareness regarding blood and plasma donation and the implementation of various government initiatives to promote blood donation camps, are anticipated to drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global blood plasma derivatives market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Albumin

Factor VIII

Factor IX

Immunoglobulin

Hyperimmune Globulin

Others

Breakup by Application:

Hemophilia

Hypogammaglobulinemia

Immunodeficiency Diseases

Von Willebrand's Disease

Others

Breakup by End User:

Hospitals

Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report

  • 1. What was the size of the global blood plasma derivatives market in 2023?
  • 2. What is the expected growth rate of the global blood plasma derivatives market during 2024-2032?
  • 3. What are the key factors driving the global blood plasma derivatives market?
  • 4. What has been the impact of COVID-19 on the global blood plasma derivatives market?
  • 5. What is the breakup of the global blood plasma derivatives market based on the type?
  • 6. What is the breakup of the global blood plasma derivatives market based on the end-user?
  • 7. What are the key regions in the global blood plasma derivatives market?
  • 8. Who are the key players/companies in the global blood plasma derivatives market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Plasma Derivatives Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Albumin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Factor VIII
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Factor IX
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Immunoglobulin
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Hyperimmune Globulin
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Hemophilia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hypogammaglobulinemia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunodeficiency Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Von Willebrand's Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 CSL Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Fusion Health Care Pvt. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Grifols S.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Kedrion S.p.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 LFB S.A.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Octapharma AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takeda Pharmaceutical Company Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis